UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Efatutazone, an Oral PPAR-γ Agonist, in Combination With Paclitaxel in Anaplastic Thyroid Cancer: Results of a Multicenter Phase 1 Trial

The journal of clinical endocrinology and metabolism, 2013-06, Vol.98 (6), p.2392-2400

2013

Volltextzugriff (PDF)

Efficient method for preparing normal and tumor tissue for RNA extraction

BioTechniques, 1995-02, Vol.18 (2), p.228

1995

Volltextzugriff (PDF)

EXPRESSION OF CYCLIN D1 IN SQUAMOUS-CELL CARCINOMAS OF THE HEAD AND NECK

International journal of oncology, 1994-09

1994

Volltextzugriff (PDF)

Phase I/II trial of vandetanib and bortezomib in adults with locally advanced or metastatic medullary thyroid cancer: Phase I results

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.5565-5565

2011

Volltextzugriff (PDF)

Activity of novel RET inhibitors against RET genotypes associated with medullary thyroid cancer

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.5559-5559

2010

Volltextzugriff (PDF)

A randomized phase II/III trial of a tumor vascular disrupting agent fosbretabulin tromethamine (CA4P) with carboplatin (C) and paclitaxel (P) in anaplastic thyroid cancer (ATC): Final survival analysis for the FACT trial

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.5502-5502

2011

Volltextzugriff (PDF)

Resistance to Tyrosine Kinase Inhibitors in Gastrointestinal Stromal Tumors

Clinical cancer research, 2009-12, Vol.15 (24), p.7510-7518

2009

Volltextzugriff (PDF)

Wealth and urbanization shape medium and large terrestrial mammal communities

Global change biology, 2021-11, Vol.27 (21), p.5446-5459

2021

Volltextzugriff (PDF)

Phase I/II Trial of Vandetanib and Bortezomib in Adults with Locally Advanced or Metastatic Medullary Thyroid Cancer

The oncologist (Dayton, Ohio), 2019-01, Vol.24 (1), p.16-e14

2019

Volltextzugriff (PDF)

Advancing urban wildlife research through a multi-city collaboration

Frontiers in ecology and the environment, 2019-05, Vol.17 (4), p.232-239

2019

Volltextzugriff (PDF)

Gentrification drives patterns of alpha and beta diversity in cities

Proceedings of the National Academy of Sciences - PNAS, 2024-04, Vol.121 (17), p.e2318596121

2024

Volltextzugriff (PDF)

Updated results from a phase 1/2 study of HPN328, a tri-specific, half-life (T1/2) extended DLL3-targeting T-cell engager in patients (pts) with small cell lung cancer (SCLC) and other neuroendocrine cancers (NEC)

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.8090-8090

2024

Volltextzugriff (PDF)

A Case Report of Sequential Use of a Yeast-CEA Therapeutic Cancer Vaccine and Anti-PD-L1 Inhibitor in Metastatic Medullary Thyroid Cancer

Frontiers in endocrinology (Lausanne), 2020-08, Vol.11

2020

Volltextzugriff (PDF)

Interim results from a phase 1/2 study of HPN328, a tri-specific, half-life (T1/2) extended DLL3-targeting T-cell engager, in patients (pts) with neuroendocrine prostate cancer (NEPC) and other neuroendocrine neoplasms (NEN)

Journal of clinical oncology, 2024-02, Vol.42 (4_suppl), p.121-121

2024

Volltextzugriff (PDF)

Pomegranate - a tropical fruit rich in bioactive compounds with health-promoting properties

Nauka Przyroda Technologie, 2015-09, Vol.9 (3)

2015

Volltextzugriff (PDF)

Health benefits of mangosteen

Nauka Przyroda Technologie, 2015-12, Vol.9 (4)

2015

Volltextzugriff (PDF)

Abstract 4547: Treatment of human medullary thyroid carcinoma (MTC) with either proteasome (Pr) or histone deacetylase (HDAC) inhibitors leads to a fall in RET mRNA levels and, in turn, a decrease in RET protein expression providing alternate strategies to reduce RET expression in a tyrosine-kinase driven disease

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.4547-4547

2011

Volltextzugriff (PDF)

A phase II study of a yeast-based therapeutic cancer vaccine, GI-6207, targeting CEA in patients with minimally symptomatic, metastatic medullary thyroid cancer

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.TPS3127-TPS3127

2013

Volltextzugriff (PDF)

Abstract 1278: Phase 1 study of CS-7017, an oral PPAR-γ agonist, in combination with paclitaxel in advanced anaplastic thyroid cancer

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.1278-1278

2011

Volltextzugriff (PDF)

Endocrine Malignancies

Cancer Consult: Expertise for Clinical Practice, 2014, p.476-479

2014

Volltextzugriff (PDF)

Molecular dynamics of diglycine nitrate studied by phase memory relaxation time of glycine radical

Ferroelectrics, 1995-10, Vol.172 (1), p.431-435

1995

Volltextzugriff (PDF)

A resonance enhancement of the phase relaxation in the electron spin echo of nitroxide covalently attached to cytochrome c

Chemical physics letters, 1995-12, Vol.247 (4), p.601-606

1995

Volltextzugriff (PDF)

Electron Spin Relaxation and ESEEM Spectroscopy of the Glycine Radical in Diglycine Nitrate Single Crystal

Acta chemica Scandinavica (Copenhagen. 1989), 1997, Vol.51, p.556-561

1997

Volltextzugriff (PDF)

A reorientation of the PO 3 -groups and radiation damage effect in ferroelectric phase transition studied by CW-EPR of PO 3 2− radical in glycine·H 3 PO 3 single crystal

Ferroelectrics. Letters section, 1998-03, Vol.23 (5-6), p.121-126

1998

Volltextzugriff (PDF)

A reorientation of the PO3-groups and radiation damage effect in ferroelectric phase transition studied by CW-EPR of PO3 2− radical in glycine·H3PO3 single crystal

Ferroelectrics. Letters section, 1998-03, Vol.23 (5-6), p.121-126

1998

Volltextzugriff (PDF)

1 – 25 von 27

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(26)
Buchkapitel
(1)

Sprache

Englisch
(27)

Erscheinungsjahr

n.n

Thema

Science & Technology
(11)
Life Sciences & Biomedicine
(10)
Humans
(4)
Oncology
(4)
Biodiversity
(3)
Biological And Medical Sciences
(3)
Cities
(3)
Wildlife
(3)
Biochemistry & Molecular Biology
(2)
Ecology
(2)
Endocrinology & Metabolism
(2)
Environmental Sciences
(2)
Environmental Sciences & Ecology
(2)
Female
(2)
Fundamental And Applied Biological Sciences. Psychology
(2)
Male
(2)
Mammals
(2)
Medical Sciences
(2)
Medullary Thyroid Cancer
(2)
Species
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Efatutazone, an Oral PPAR-γ Agonist, in Combination With Paclitaxel in Anaplastic Thyroid Cancer: Results of a Multicenter Phase 1 Trial

Efficient method for preparing normal and tumor tissue for RNA extraction

EXPRESSION OF CYCLIN D1 IN SQUAMOUS-CELL CARCINOMAS OF THE HEAD AND NECK

Phase I/II trial of vandetanib and bortezomib in adults with locally advanced or metastatic medullary thyroid cancer: Phase I results

Activity of novel RET inhibitors against RET genotypes associated with medullary thyroid cancer

A randomized phase II/III trial of a tumor vascular disrupting agent fosbretabulin tromethamine (CA4P) with carboplatin (C) and paclitaxel (P) in anaplastic thyroid cancer (ATC): Final survival analysis for the FACT trial

Resistance to Tyrosine Kinase Inhibitors in Gastrointestinal Stromal Tumors

Wealth and urbanization shape medium and large terrestrial mammal communities

Phase I/II Trial of Vandetanib and Bortezomib in Adults with Locally Advanced or Metastatic Medullary Thyroid Cancer

Advancing urban wildlife research through a multi-city collaboration

Gentrification drives patterns of alpha and beta diversity in cities

Updated results from a phase 1/2 study of HPN328, a tri-specific, half-life (T1/2) extended DLL3-targeting T-cell engager in patients (pts) with small cell lung cancer (SCLC) and other neuroendocrine cancers (NEC)

A Case Report of Sequential Use of a Yeast-CEA Therapeutic Cancer Vaccine and Anti-PD-L1 Inhibitor in Metastatic Medullary Thyroid Cancer

Interim results from a phase 1/2 study of HPN328, a tri-specific, half-life (T1/2) extended DLL3-targeting T-cell engager, in patients (pts) with neuroendocrine prostate cancer (NEPC) and other neuroendocrine neoplasms (NEN)

Pomegranate - a tropical fruit rich in bioactive compounds with health-promoting properties

Health benefits of mangosteen

A phase II study of a yeast-based therapeutic cancer vaccine, GI-6207, targeting CEA in patients with minimally symptomatic, metastatic medullary thyroid cancer

Abstract 1278: Phase 1 study of CS-7017, an oral PPAR-γ agonist, in combination with paclitaxel in advanced anaplastic thyroid cancer

Endocrine Malignancies

Molecular dynamics of diglycine nitrate studied by phase memory relaxation time of glycine radical

A resonance enhancement of the phase relaxation in the electron spin echo of nitroxide covalently attached to cytochrome c

Electron Spin Relaxation and ESEEM Spectroscopy of the Glycine Radical in Diglycine Nitrate Single Crystal

A reorientation of the PO 3 -groups and radiation damage effect in ferroelectric phase transition studied by CW-EPR of PO 3 2− radical in glycine·H 3 PO 3 single crystal

A reorientation of the PO3-groups and radiation damage effect in ferroelectric phase transition studied by CW-EPR of PO3 2− radical in glycine·H3PO3 single crystal

Suchergebnisse filtern